Search

Your search keyword '"Kirk, A D"' showing total 3,858 results

Search Constraints

Start Over You searched for: Author "Kirk, A D" Remove constraint Author: "Kirk, A D" Publication Year Range Last 50 years Remove constraint Publication Year Range: Last 50 years
3,858 results on '"Kirk, A D"'

Search Results

1. Federated Variational Inference for Bayesian Mixture Models

2. Practical Design and Benchmarking of Generative AI Applications for Surgical Billing and Coding

3. Outcome-guided spike-and-slab Lasso Biclustering: A Novel Approach for Enhancing Biclustering Techniques for Gene Expression Analysis

4. Proteomic signature of HIV-associated subclinical left atrial remodeling and incident heart failure

5. Annealed variational mixtures for disease subtyping and biomarker discovery

6. Energy Transport Among Highly-Polarized Atoms

7. Permutation invariant multi-output Gaussian Processes for drug combination prediction in cancer

8. VICatMix: variational Bayesian clustering and variable selection for discrete biomedical data

12. Impact of HLA class I functional divergence on HIV control

14. The forecasted prevalence of comorbidities and multimorbidity in people with HIV in the United States through the year 2030: A modeling study.

15. Hospital Readmissions Among Persons With Human Immunodeficiency Virus in the United States and Canada, 2005–2018: A Collaboration of Cohort Studies

16. Substance use and other factors associated with COVID-19 vaccine uptake among people at risk for or living with HIV: Findings from the C3PNO consortium

17. Context and correlates of providing assistance with someone’s first injection in the AIDS linked to the IntraVenous Experience cohort, Baltimore, MD

18. Bayesian outcome-guided multi-view mixture models with applications in molecular precision medicine

22. Bayesian nonparametric mixture inconsistency for the number of components: How worried should we be in practice?

23. Hepatitis B care cascade among people with HIV/HBV coinfection in the North American AIDS Cohort Collaboration on Research and Design, 2012–2016

24. Day-to-day impact of COVID-19 and other factors associated with risk of nonfatal overdose among people who use unregulated drugs in five cities in the United States and Canada

25. Use of COVID-19 testing in the first year of the COVID-19 pandemic among cohorts of people at the intersection of drug use and HIV

26. Factors associated with self-reported avoidance of harm reduction services during the COVID-19 pandemic by people who use drugs in five cities in the United States and Canada

27. The relationship of alcohol and other drug use during the COVID-19 pandemic among people with or at risk of HIV; A cross-sectional survey of people enrolled in Collaborating Consortium of Cohorts Producing NIDA Opportunities (C3PNO) cohorts

31. Discrimination and Calibration of the Veterans Aging Cohort Study Index 2.0 for Predicting Mortality Among People With Human Immunodeficiency Virus in North America

32. Bayesian profile regression for clustering analysis involving a longitudinal response and explanatory variables

33. Advancing mouse models for transplantation research

34. Topological Approximate Bayesian Computation for Parameter Inference of an Angiogenesis Model

35. Tailored Bayes: a risk modelling framework under unequal misclassification costs

37. Human Immunodeficiency Virus transmission by HIV Risk Group and Along the HIV Care Continuum: A Contrast of 6 US Cities

38. Trans-ancestral fine-mapping of MHC reveals key amino acids associated with spontaneous clearance of hepatitis C in HLA-DQβ1

39. HIV, psychological resilience, and substance misuse during the COVID-19 pandemic: A multi-cohort study

41. Africa-specific human genetic variation near CHD1L associates with HIV-1 load

42. Kernel learning approaches for summarising and combining posterior similarity matrices

43. Two-step penalised logistic regression for multi-omic data with an application to cardiometabolic syndrome

49. Current and Past Immunodeficiency Are Associated With Higher Hospitalization Rates Among Persons on Virologically Suppressive Antiretroviral Therapy for up to 11 Years

50. Hospitalization Rates and Causes Among Persons With HIV in the United States and Canada, 2005–2015

Catalog

Books, media, physical & digital resources